Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tabomet 1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Albia Biocare

Salt Composition

Metformin (1000mg)

Overview Tabomet 1000mg Tablet SR

Metformin 1000mg Extended-Release tablets are prescribed for managing type 2 diabetes. This medication regulates blood glucose, mitigating the risk of diabetes-related complications. It's also indicated for treating Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, take Metformin 1000mg ER tablets with food. Consistent daily dosing is crucial for effectiveness; discontinue only under physician guidance. Maintaining a healthy lifestyle, including prescribed diet and exercise, is essential for successful diabetes management. Commonly reported side effects include nausea, diarrhea, vomiting, gas, weakness, indigestion, abdominal pain, headache, and appetite loss. Concurrent use with other diabetes medications, alcohol consumption, or missed meals may lead to hypoglycemia (low blood sugar). Regular blood glucose monitoring is advised. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption to reduce the potential for adverse reactions.

Uses of Tabomet 1000mg Tablet SR

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Tabomet 1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Tabomet 1000mg Tablet SR should be taken with a meal.

Common Side effects of Tabomet 1000mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Tabomet 1000mg Tablet SR:

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tabomet 1000mg Tablet SR is to be taken with food.

How Tabomet 1000mg Tablet SR works:

Metformin 1000mg Extended-Release tablets are a biguanide class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tabomet 1000mg SR tablets with alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Tabomet 1000mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, clinical data in pregnant women are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Tabomet 1000mg tablets require careful consideration during lactation. Nursing mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, the use of Tabomet 1000mg SR tablets requires careful monitoring. Dosage modification of Tabomet 1000mg SR tablets may be necessary. Physician consultation is advised. In cases of severe kidney disease, however, Tabomet 1000mg SR tablets are not recommended.

LiverLiverUNSAFE

Extended-release Tabomet 1000mg tablets are likely to be detrimental for individuals with hepatic impairment and should be avoided. Seek medical advice before use.

What if you forget to take Tabomet 1000mg Tablet SR :

Should you forget a Tabomet 1000mg Tablet SR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Tabomet 1000mg Tablet SR

LabelValue
Type of Compound Guanidine-based compound
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Tabomet 1000mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's self-produced insulin. Consequently, blood glucose levels rise. Tabomet 1000mg Tablet SR employs a multifaceted approach to lower elevated blood sugar. This medication reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in muscles and other organs. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Weight loss has been observed in overweight and obese individuals taking Tabomet 1000mg SR tablets. This effect may also be seen in overweight or obese patients predisposed to diabetes, as well as those with insulin resistance or sensitivity. However, self-prescribing Tabomet 1000mg SR for weight management is strongly discouraged; physician consultation is essential.
Metformin 1000mg extended-release tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing the body's sensitivity to pancreatic insulin, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin 1000mg extended-release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism that avoids excessive insulin release. Beyond glycemic control, this medication also assists in mitigating weight gain.
The extended-release Tabomet 1000mg tablet typically doesn't induce drowsiness and is generally well-received. Infrequently, however, Tabomet 1000mg Tablet SR use may result in sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Tabomet 1000mg Tablet SR treatment.
Administer Tabomet 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily prescriptions, consume the tablet in the morning with breakfast. If prescribed twice daily, take one tablet with breakfast and the other with dinner. For thrice-daily regimens, distribute the tablets among breakfast, lunch, and dinner. Ingesting Tabomet 1000mg sustained-release tablets with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either don't produce sufficient insulin or their bodies don't react effectively to the insulin they produce. This leads to elevated blood sugar levels. Tabomet 1000mg Tablet SR works through multiple mechanisms to lower these high blood glucose levels. It reduces glucose production by the liver, diminishes glucose absorption from the intestines following meals, and enhances the insulin sensitivity of bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream. Furthermore, it promotes a more effective response to naturally produced insulin.
Weight loss has been observed in overweight or obese individuals taking Tabomet 1000mg SR tablets. This effect may also be seen in overweight and obese patients predisposed to diabetes. Furthermore, insulin-resistant or insulin-sensitive patients may experience weight reduction. However, self-medicating with Tabomet for weight loss is strongly discouraged; physician consultation is mandatory.
Metformin 1000mg extended-release tablets are frequently prescribed as an initial treatment for hyperglycemia. This medication manages blood glucose levels by enhancing insulin sensitivity, reducing hepatic glucose production, and decreasing intestinal glucose absorption. Differing from other oral hypoglycemics, monotherapy with Metformin 1000mg extended-release tablets infrequently leads to hypoglycemia due to its mechanism of action that avoids excessive insulin secretion. Beyond glycemic control, it also aids in weight management.
The extended-release Tabomet 1000mg tablet generally doesn't induce drowsiness and is well-received. Nevertheless, it can infrequently lead to sleep disturbances and insomnia. Drowsiness may signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Tabomet 1000mg SR treatment.
Administer Tabomet 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, take the tablet in the morning with breakfast. Twice-daily regimens should involve one tablet with breakfast and the other with dinner. If three daily doses are indicated, distribute them with breakfast, lunch, and dinner. Consuming Tabomet 1000mg SR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's insulin production. This leads to elevated blood glucose levels. The 1000mg sustained-release Tabomet tablet works through multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream and improves the body's natural insulin response.
Individuals overweight or obese have experienced weight reduction while using Tabomet 1000mg SR tablets. This effect may also be observed in overweight or obese patients predisposed to diabetes. Furthermore, weight loss can occur in insulin-resistant or insulin-sensitive individuals. However, self-prescribing Tabomet for weight management is strongly discouraged; physician consultation is essential.
Metformin 1000mg extended-release tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and decreasing intestinal glucose absorption. Unlike some other oral hypoglycemics, Metformin 1000mg extended-release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism of action which avoids excessive insulin secretion. Beyond glycemic control, it also aids in weight management.
Tabomet 1000mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Tabomet 1000mg sustained-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired renal function. Consult your physician if fatigue or sleepiness develops during Tabomet 1000mg sustained-release tablet treatment.
Administer Tabomet 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily prescriptions, morning administration with breakfast is recommended. For twice-daily regimens, divide the dose between morning and evening meals. Three times daily dosing should incorporate morning, midday, and evening administration. Consuming Tabomet 1000mg SR with food mitigates potential gastrointestinal distress including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Tabomet 1000mg Tablet SR
34
MRP 40
15% off